Discontinuing VEGF-targeted Therapy for Progression Versus Toxicity Affects Outcomes of Second-line Therapies in Metastatic Renal Cell Carcinoma.
| Image |  |
|---|---|
| Description | scientific article published on 12 January 2017 |
| Author/s |
author: Frede Donskov Laurence Albiges Sun Young Rha Guillermo de Velasco Ravindran Kanesvaran Toni K Choueiri Benoit Beuselinck |
| Publication date | January 12, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |